| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of VASN mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1605593 | 6480464 | Estradiol promotes the reaction [ESR2 protein affects the expression of VASN mRNA] | CTD | PMID:20404318 |
| 17beta-estradiol | increases expression | ISO | RGD:1605593 | 6480464 | Estradiol results in increased expression of VASN mRNA | CTD | PMID:23019147 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1605593 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of VASN mRNA | CTD | PMID:21802500 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of VASN mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1598149 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of VASN mRNA | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1598149 | 6480464 | Tetrachlorodibenzodioxin affects the expression of VASN mRNA | CTD | PMID:22298810 |
| 2-methylcholine | affects expression | ISO | RGD:1605593 | 6480464 | beta-methylcholine affects the expression of VASN mRNA | CTD | PMID:21179406 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | Benzo(a)pyrene promotes the reaction [AHR protein binds to VASN promoter] | CTD | PMID:19654925 |
| benzo[a]pyrene | increases expression | ISO | RGD:1605593 | 6480464 | Benzo(a)pyrene results in increased expression of VASN mRNA | CTD | PMID:20064835 |
| bisphenol A | increases expression | ISO | RGD:1605593 | 6480464 | bisphenol A results in increased expression of VASN mRNA | CTD | PMID:23019147 |
| cadmium dichloride | increases methylation | ISO | RGD:1598149 | 6480464 | Cadmium Chloride results in increased methylation of VASN promoter | CTD | PMID:22457795 |
| ciguatoxin CTX1B | affects expression | EXP | | 6480464 | Ciguatoxins affects the expression of VASN mRNA | CTD | PMID:18353800 |
| cisplatin | increases expression | ISO | RGD:1605593 | 6480464 | Cisplatin results in increased expression of VASN mRNA | CTD | PMID:19561079 |
| cobalt atom | multiple interactions | ISO | RGD:1605593 | 6480464 | [tungsten carbide co-treated with Cobalt] results in increased expression of VASN mRNA | CTD | PMID:23052192 |
| copper(2+) sulfate | decreases expression | ISO | RGD:1605593 | 6480464 | Copper Sulfate results in decreased expression of VASN mRNA | CTD | PMID:19549813 |
| cytarabine | decreases expression | ISO | RGD:1605593 | 6480464 | Cytarabine results in decreased expression of VASN mRNA | CTD | PMID:21198554 |
| dibutyl phthalate | increases expression | ISO | RGD:1598149 | 6480464 | Dibutyl Phthalate results in increased expression of VASN mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of VASN mRNA | CTD | PMID:17361019 PMID:21266533 |
| dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of VASN mRNA | CTD | PMID:21266533 |
| genistein | increases expression | ISO | RGD:1605593 | 6480464 | Genistein results in increased expression of VASN mRNA | CTD | PMID:23019147 |
| menadione | affects expression | ISO | RGD:1605593 | 6480464 | Vitamin K 3 affects the expression of VASN mRNA | CTD | PMID:20044591 |
| methotrexate | affects expression | EXP | | 6480464 | Methotrexate affects the expression of VASN mRNA | CTD | PMID:18502557 |
| paracetamol | increases expression | ISO | RGD:1605593 | 6480464 | Acetaminophen results in increased expression of VASN mRNA | CTD | PMID:21420995 |
| phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of VASN mRNA | CTD | PMID:23091169 |
| pioglitazone | multiple interactions | ISO | RGD:1605593 | 6480464 | pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of VASN mRNA]; more ... | CTD | PMID:20847119 |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of VASN mRNA | CTD | PMID:18445702 |
| quercetin | decreases expression | ISO | RGD:1605593 | 6480464 | Quercetin results in decreased expression of VASN mRNA | CTD | PMID:21632981 |
| rosiglitazone | multiple interactions | ISO | RGD:1605593 | 6480464 | rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of VASN mRNA]; more ... | CTD | PMID:20847119 |
| sirolimus | decreases expression | ISO | RGD:1598149 | 6480464 | Sirolimus results in decreased expression of VASN mRNA | CTD | PMID:17028423 |
| tacrolimus hydrate | decreases expression | ISO | RGD:1598149 | 6480464 | Tacrolimus results in decreased expression of VASN mRNA | CTD | PMID:17028423 |
| tert-butyl hydroperoxide | multiple interactions | ISO | RGD:1605593 | 6480464 | pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of VASN mRNA]; more ... | CTD | PMID:20847119 |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:1605593 | 6480464 | tert-Butylhydroperoxide results in increased expression of VASN mRNA | CTD | PMID:20847119 |
| tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of VASN mRNA | CTD | PMID:17484886 |
| troglitazone | multiple interactions | ISO | RGD:1605593 | 6480464 | [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of VASN mRNA; more ... | CTD | PMID:20847119 |